Department of Gynecology and Obstetrics (Musselman), Johns Hopkins Hospital, Baltimore, Maryland.
Department of Obstetrics and Gynecology (Shin, Havryliuk, Schiffman, and Fenster), Weill Cornell Medicine, New York, New York.
J Minim Invasive Gynecol. 2024 Jul;31(7):592-600.e2. doi: 10.1016/j.jmig.2024.04.016. Epub 2024 Apr 26.
Although medical, interventional, and surgical treatment options for fibroids have expanded over the last decade, many patients are not thoroughly counseled about all available therapies. Patients desire a more comprehensive approach with shared decision-making tailored to their health goals. The aim of this study is to assess patient knowledge regarding treatment options before and after consultation with a multidisciplinary fibroid center.
Prospective survey study.
Academic medical center in New York, NY.
Patients who presented for initial consultation with a multidisciplinary fibroid program from July 2021 through January 2022.
Patients were offered same-day office consultation with a minimally invasive gynecologic surgeon (MIGS) followed by a telemedicine visit with an interventional radiologist (IR) within 3 weeks of the appointment request. Collaborative discussions were held between providers regarding patient care. Patients were asked to complete the survey following both appointments. Data was collected regarding demographics, prior evaluation of fibroids, knowledge about treatment options, and overall experience.
A total of 102 patients completed the survey (response rate 77%). A majority (55.9%) had known about their fibroids for at least 2 years. Most patients sought out the fibroid program for a 2nd (28.4%), 3rd (22.5%) or 4th (7.8%) opinion. Notably, 35.3% of patients who had previously been seen by an obstetrician-gynecologist (OB/GYN) were not offered any treatment. Of those who had been offered treatment, 24.5% were counseled on medical management with oral contraceptives, 28.4% on surgical options, and 5.9% on uterine artery embolization. Nearly all patients (86.3%) endorsed that they would not have sought 2 separate consultations had it not been for the program. Patients were overall well-informed after their experience, with 95.1% reporting they were more knowledgeable about their options and none reporting the 2 separate consults created more confusion for them.
Many patients with symptomatic fibroids seeking secondary opinions have not been adequately counseled on fibroid management options. A collaborative approach to fibroid management better educates patients, provides an opportunity to be thoroughly counseled by the specialists performing either surgical or interventional procedures, and increases patient knowledge about fibroid treatment options.
尽管过去十年间,治疗子宫肌瘤的医学、介入和手术选择有所增加,但许多患者并未充分了解所有可用的治疗方法。患者希望采用更全面的方法,并根据他们的健康目标进行共同决策。本研究旨在评估患者在与多学科子宫肌瘤中心咨询前后对治疗选择的了解程度。
前瞻性调查研究。
纽约州纽约市的一所学术医疗中心。
2021 年 7 月至 2022 年 1 月期间,因多发性子宫肌瘤首次就诊的患者参加了多学科子宫肌瘤项目。
患者被安排在预约当天与微创妇科医生(MIGS)进行门诊咨询,并在预约请求后的 3 周内通过远程医疗与介入放射科医生(IR)进行远程会诊。医生之间就患者护理进行了协作讨论。患者在两次就诊后完成了调查。收集了关于人口统计学、子宫肌瘤既往评估、治疗选择知识和总体体验的数据。
共有 102 名患者完成了调查(应答率为 77%)。大多数患者(55.9%)至少已知道自己患有子宫肌瘤 2 年。大多数患者因第二次(28.4%)、第三次(22.5%)或第四次(7.8%)就诊而寻求子宫肌瘤项目。值得注意的是,35.3%的曾在妇产科医生处就诊的患者未被提供任何治疗方案。那些曾被提供治疗方案的患者中,24.5%接受了口服避孕药的药物治疗建议,28.4%接受了手术选择建议,5.9%接受了子宫动脉栓塞治疗建议。几乎所有患者(86.3%)表示,如果不是因为该项目,他们不会寻求 2 次单独的咨询。患者在就诊后整体了解程度较高,95.1%的患者表示他们对治疗方案的了解更加深入,没有患者表示 2 次单独的咨询使他们感到更加困惑。
许多寻求第二意见的有症状子宫肌瘤患者,并未充分了解子宫肌瘤的管理选择。对子宫肌瘤管理采用协作方法可以更好地教育患者,为接受手术或介入治疗的专家提供充分咨询的机会,并提高患者对子宫肌瘤治疗选择的了解。